IHAM
TARA icon

Integral Health Asset Management’s Protara Therapeutics TARA Stock Holding History

Integral Health Asset Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.12M Sell
1,750,000
-500,000
-22% -$2.96M 0.44% 64
2025
Q4 		$12M Buy
2,250,000
+850,000
+61% +$4.73M 0.6% 54
2025
Q3 		$6.09M Hold
1,400,000
– – 0.41% 66
2025
Q2 		$4.24M Hold
1,400,000
– – 0.39% 59
2025
Q1 		$5.96M Hold
1,400,000
– – 0.63% 47
2024
Q4 		$7.39M Buy
+1,400,000
New +$4.52M 0.63% 52

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Integral Health Asset Management's TARA Position: Q1 2026 in Review

Integral Health Asset Management reduced its Protara Therapeutics (TARA) stake by 22% in Q1 2026, selling an estimated $2.96M and leaving 1,750,000 shares worth $9.12M. The position accounts for 0.44% of the portfolio, ranked #64.

Integral Health Asset Management first reported a position in TARA in Q4 2024 and has held it in 6 quarters since. The position peaked at $12M in Q4 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Integral Health Asset Management held 1,750,000 shares of Protara Therapeutics worth $9.12M as of Q1 2026.
  • Integral Health Asset Management sold 500,000 Protara Therapeutics shares in Q1 2026, an estimated $2.96M.
  • Protara Therapeutics made up 0.44% of Integral Health Asset Management's portfolio in Q1 2026, its #64 holding.
  • Integral Health Asset Management first reported a position in Protara Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Integral Health Asset Management's Protara Therapeutics position peaked at $12M in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.